To investigate the prosenescence effects of Ccl2 in accelerated aging at the organismal level, we developed an experimental model that combines progeria induced by a mutation in the Lmna gene and systemic Ccl2 overexpression. The gene discussed is CCL2; the disease is progeroid syndrome.